Cost Curve News - News - https://www.costcurvenews.com/blog/page/11/

The Government Has Green-Lit a Major Change to 340B Payments … With Some Limits

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

5 months ago

AstraZeneca ‘Absolutely Considering’ Pharm-to-Table

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

Drugs From Europe Will Be Hit With a 15% Tariff, But Key Details Are Still Cloudy

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

RFK Jr. Takes Aim at the Preventive Services Task Force, Injecting More Uncertainty into Public Health

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

A USC Analysis Tallies the Potential Savings Associated with ‘Delinking’ Middleman Comp from List Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

Roche Is Considering ‘Pharm to Table’ as a Weapon to Use Against Middlemen

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

‘Pseudo-Pharmas’ Are Getting Bigger … and Getting Creative When It Comes to Pricing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

J&J Publishes Its Annual Transparency Report, Discloses It Gave Back 58% of Sales in Rebates, Discounts, and Fees

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

NIH Cuts Would Mean Dozens of New Drugs Could Be Lost, CBO Says. That’s Probably an Undercount

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv